Lite Strategy Inc. Common Stock (LITS)
Stock · NASDAQ · Health Care
$1.15as of 10/16/2026
Price chart
Active signals
LITS Signal Track Record
How signals performed across all stocks →What LITS's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 39 | -2.9% | 49% | September 17, 2026 |
| Bollinger Band Breakdown | 26 | -4.0% | 42% | August 7, 2026 |
| Bollinger Band Breakout | 20 | +3.1% | 55% | September 21, 2026 |
| 200-Day Moving Average TouchActive now | 3 | -15.7% | 33% | September 14, 2026 |
| Any 20-session window (baseline) | -5.0% | 40% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About LITS
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. It is also involved in holding Litecoin tokens as a primary reserve asset. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, Cali…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 5
- Website
- litestrategy.com/
Fundamentals
- 1-day range
- $1.14$1.21
- Market cap
- $31.61M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- $-1.74
- Dividend yield
- —
- Beta
- 0.06
- Avg. volume
- 482.5K
- Ex-dividend date
- November 16, 2023
- Dividend pay date
- December 6, 2023
Lite Strategy Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- LITSLite Strategy Inc. Common Stock$1.15▼ 4.17%Market cap $31.61MP/E —$0.6888$2.26
- QUCYQuantum Cyber N.V. Ordinary Shares$1.06▼ 2.75%Market cap $31.42MP/E —$0.3$4.93
- UPCUniverse Pharmaceuticals Inc. Class A Ordinary Shares$3.93▼ 5.30%Market cap $31.35MP/E —$2$17.96
- BCTXBriaCell Therapeutics Corp. Common Shares$3.4▼ 9.81%Market cap $30.01MP/E —$3.68$20.4
- ENLVEnlivex Ltd. Ordinary Shares$0.205▼ 8.48%Market cap $33.33MP/E 0.00$0.21$27.15
- ACTUActuate Therapeutics Inc. Common stock$0.605▲ 21.00%Market cap $29.43MP/E —$0.41$8.27
- MIRAMIRA Pharmaceuticals Inc. Common Stock$0.632▼ 3.95%Market cap $28.50MP/E —$0.6$2.45
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| LITS Lite Strategy Inc. Common Stock | $31.61M | — | $1.15 | ▼ 4.17% | $0.6888$2.26 |
| QUCY Quantum Cyber N.V. Ordinary Shares | $31.42M | — | $1.06 | ▼ 2.75% | $0.3$4.93 |
| UPC Universe Pharmaceuticals Inc. Class A Ordinary Shares | $31.35M | — | $3.93 | ▼ 5.30% | $2$17.96 |
| BCTX BriaCell Therapeutics Corp. Common Shares | $30.01M | — | $3.4 | ▼ 9.81% | $3.68$20.4 |
| ENLV Enlivex Ltd. Ordinary Shares | $33.33M | 0.00 | $0.205 | ▼ 8.48% | $0.21$27.15 |
| ACTU Actuate Therapeutics Inc. Common stock | $29.43M | — | $0.605 | ▲ 21.00% | $0.41$8.27 |
| MIRA MIRA Pharmaceuticals Inc. Common Stock | $28.50M | — | $0.632 | ▼ 3.95% | $0.6$2.45 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Which stocks are moving on Thursday?ChartMill · 9/24/2026
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga · 9/24/2026
Insider Activity
Insider Actions →- Flynn James P · June 24, 2026 · Buy25.0K @ $0.8555
Institutional Ownership
March 31, 2026
- Total shares held
- 5.75M
- Total value held
- $6.67M
- Institutional holders
- 33
- Unknown1.74M
- Unknown1.04M
- Unknown767.5K
- Unknown614.4K
- Unknown401.1K
- Unknown333.5K
- Unknown157.9K
- Unknown136.0K
- Unknown115.0K
- Unknown80.2K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Lite Strategy Reports Q4 EPS Improvement and Files Prospectus
Lite Strategy reported fourth-quarter earnings per share of $(0.38), an improvement from $(0.40) in the same period last year. The company also filed a prospectus for an offering of 1.889 million common shares on behalf of selling shareholders. These updates provide context for the stock's current trading range between $0.69 and $2.97.
Lite Strategy Reports Q4 EPS Improvement and Files Prospectus. Lite Strategy reported fourth-quarter earnings per share of $(0.38), an improvement from $(0.40) in the same period last year. The company also filed a prospectus for an offering of 1.889 million common shares on behalf of selling shareholders. These updates provide context for the stock's current trading range between $0.69 and $2.97.